GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Enterprise Value

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Enterprise Value : ₺19,354 Mil (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value is ₺19,354 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₺691 Mil. Therefore, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT ratio for today is 28.03.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value is ₺19,354 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₺956 Mil. Therefore, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBITDA ratio for today is 20.23.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value is ₺19,354 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₺8,152 Mil. Therefore, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-Revenue ratio for today is 2.37.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Enterprise Value Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Enterprise Value Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial - - 4,239.57 14,749.54 14,658.97

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,749.54 14,133.48 12,261.63 18,776.47 14,658.97

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19353.558/690.513
=28.03

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Enterprise Value is ₺19,354 Mil.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺691 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=19353.558/956.482
=20.23

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Enterprise Value is ₺19,354 Mil.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺956 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19353.558/8151.619
=2.37

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Enterprise Value is ₺19,354 Mil.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺8,152 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Enterprise Value Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines